Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Its structure enables selective binding to enzyme active sites, enhancing drug efficacy. Commonly employed in the preparation of antitumor and anti-inflammatory compounds due to its electron-withdrawing trifluoromethyl group and heterocyclic framework. Also utilized in agrochemical research for designing bioactive molecules with improved metabolic stability and lipophilicity.